{
  "actions": [
    {
      "acted_at": "2021-02-03",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2021-02-03",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s187-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "117",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-02-03",
  "number": "187",
  "official_title": "A bill to amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr728-117",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Pandemic Emergency Manufacturing Act of 2021",
  "sponsor": {
    "bioguide_id": "W000817",
    "district": null,
    "name": "Warren, Elizabeth",
    "state": "MA",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-02-03",
  "subjects": [
    "Blood and blood diseases",
    "Cardiovascular and respiratory health",
    "Congressional oversight",
    "Corporate finance and management",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Emergency medical services and trauma care",
    "Executive agency funding and structure",
    "Federal officials",
    "Genetics",
    "Government ethics and transparency, public corruption",
    "Government information and archives",
    "Government studies and investigations",
    "Health",
    "Health personnel",
    "Health technology, devices, supplies",
    "Immunology and vaccination",
    "Indian social and development programs",
    "Infectious and parasitic diseases",
    "Inflation and prices",
    "Licensing and registrations",
    "Manufacturing",
    "Marketing and advertising",
    "Medical tests and diagnostic methods",
    "Minority health",
    "Prescription drugs",
    "Public contracts and procurement",
    "Public participation and lobbying",
    "State and local government operations",
    "Strategic materials and reserves",
    "Worker safety and health"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2021-02-03",
    "date": "2021-03-24T19:00:38Z",
    "text": "Pandemic Emergency Manufacturing Act of 2021\n\nThis bill establishes within the Department of Health and Human Services (HHS) an Emergency Office of Manufacturing for Public Health to manufacture and distribute medical products to address COVID-19 (i.e., coronavirus disease 2019) or medical products that are on shortage or vulnerable to shortage.\n\nThe office must (1) obtain the rights to manufacture the applicable medicines, ingredients, diagnostic tests, medical devices, personal protective equipment, and supplies; (2) manufacture or contract to manufacture such items; and (3) construct, or enter into construction contracts for, facilities to manufacture certain medicines, such as vaccines.\n\nHHS may issue involuntary licenses allowing the office to make, use, sell, import, or export an invention related to an applicable drug, biological product, or device and to use clinical trial data and confidential information. Such a license must provide the rights holder with reasonable compensation.\n\nThe office must (1) provide such COVID-19 products at no cost to federal, state, local, and other health programs and certain domestic health care providers and suppliers; (2) offer COVID-19 products at cost to other commercial and international entities; and (3) offer other medical products to entities at a fair price, based on cost and other considerations.\n\nThe office shall prioritize the manufacture of certain COVID-19 products and meet manufacturing timelines specified in the bill."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Pandemic Emergency Manufacturing Act of 2021",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Pandemic Emergency Manufacturing Act of 2021",
      "type": "short"
    }
  ],
  "updated_at": "2023-03-08T20:12:14Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s187.xml"
}